Global Artificial Intelligence Drug R&D Market Research Report 2023
SKU ID : QYR-23550628 | Publishing Date : 18-Apr-2023
Detailed TOC of Global Artificial Intelligence Drug R&D Market Research Report 2023
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 AI Platfrom
1.2.3 Analytics Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence Drug R&D Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Discovery
1.3.3 Precision Medicine
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Drug R&D Market Perspective (2018-2029)
2.2 Artificial Intelligence Drug R&D Growth Trends by Region
2.2.1 Global Artificial Intelligence Drug R&D Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence Drug R&D Historic Market Size by Region (2018-2023)
2.2.3 Artificial Intelligence Drug R&D Forecasted Market Size by Region (2024-2029)
2.3 Artificial Intelligence Drug R&D Market Dynamics
2.3.1 Artificial Intelligence Drug R&D Industry Trends
2.3.2 Artificial Intelligence Drug R&D Market Drivers
2.3.3 Artificial Intelligence Drug R&D Market Challenges
2.3.4 Artificial Intelligence Drug R&D Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence Drug R&D Players by Revenue
3.1.1 Global Top Artificial Intelligence Drug R&D Players by Revenue (2018-2023)
3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence Drug R&D Revenue
3.4 Global Artificial Intelligence Drug R&D Market Concentration Ratio
3.4.1 Global Artificial Intelligence Drug R&D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug R&D Revenue in 2022
3.5 Artificial Intelligence Drug R&D Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence Drug R&D Product Solution and Service
3.7 Date of Enter into Artificial Intelligence Drug R&D Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence Drug R&D Breakdown Data by Type
4.1 Global Artificial Intelligence Drug R&D Historic Market Size by Type (2018-2023)
4.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2024-2029)
5 Artificial Intelligence Drug R&D Breakdown Data by Application
5.1 Global Artificial Intelligence Drug R&D Historic Market Size by Application (2018-2023)
5.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Intelligence Drug R&D Market Size (2018-2029)
6.2 North America Artificial Intelligence Drug R&D Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Intelligence Drug R&D Market Size by Country (2018-2023)
6.4 North America Artificial Intelligence Drug R&D Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence Drug R&D Market Size (2018-2029)
7.2 Europe Artificial Intelligence Drug R&D Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Intelligence Drug R&D Market Size by Country (2018-2023)
7.4 Europe Artificial Intelligence Drug R&D Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size (2018-2029)
8.2 Asia-Pacific Artificial Intelligence Drug R&D Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence Drug R&D Market Size (2018-2029)
9.2 Latin America Artificial Intelligence Drug R&D Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Intelligence Drug R&D Market Size by Country (2018-2023)
9.4 Latin America Artificial Intelligence Drug R&D Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size (2018-2029)
10.2 Middle East & Africa Artificial Intelligence Drug R&D Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM Watson
11.1.1 IBM Watson Company Detail
11.1.2 IBM Watson Business Overview
11.1.3 IBM Watson Artificial Intelligence Drug R&D Introduction
11.1.4 IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.1.5 IBM Watson Recent Development
11.2 BioXel
11.2.1 BioXel Company Detail
11.2.2 BioXel Business Overview
11.2.3 BioXel Artificial Intelligence Drug R&D Introduction
11.2.4 BioXel Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.2.5 BioXel Recent Development
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Detail
11.3.2 Insilico Medicine Business Overview
11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Introduction
11.3.4 Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.3.5 Insilico Medicine Recent Development
11.4 Gatehouse Bio
11.4.1 Gatehouse Bio Company Detail
11.4.2 Gatehouse Bio Business Overview
11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Introduction
11.4.4 Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.4.5 Gatehouse Bio Recent Development
11.5 Google DeepMind
11.5.1 Google DeepMind Company Detail
11.5.2 Google DeepMind Business Overview
11.5.3 Google DeepMind Artificial Intelligence Drug R&D Introduction
11.5.4 Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.5.5 Google DeepMind Recent Development
11.6 Genpact Cora
11.6.1 Genpact Cora Company Detail
11.6.2 Genpact Cora Business Overview
11.6.3 Genpact Cora Artificial Intelligence Drug R&D Introduction
11.6.4 Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.6.5 Genpact Cora Recent Development
11.7 Cyclica Inc
11.7.1 Cyclica Inc Company Detail
11.7.2 Cyclica Inc Business Overview
11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Introduction
11.7.4 Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.7.5 Cyclica Inc Recent Development
11.8 QuantumBlack
11.8.1 QuantumBlack Company Detail
11.8.2 QuantumBlack Business Overview
11.8.3 QuantumBlack Artificial Intelligence Drug R&D Introduction
11.8.4 QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.8.5 QuantumBlack Recent Development
11.9 Nq Medical
11.9.1 Nq Medical Company Detail
11.9.2 Nq Medical Business Overview
11.9.3 Nq Medical Artificial Intelligence Drug R&D Introduction
11.9.4 Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.9.5 Nq Medical Recent Development
11.10 Phenomic AI
11.10.1 Phenomic AI Company Detail
11.10.2 Phenomic AI Business Overview
11.10.3 Phenomic AI Artificial Intelligence Drug R&D Introduction
11.10.4 Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.10.5 Phenomic AI Recent Development
11.11 Palantir Technologies
11.11.1 Palantir Technologies Company Detail
11.11.2 Palantir Technologies Business Overview
11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Introduction
11.11.4 Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2018-2023)
11.11.5 Palantir Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Artificial Intelligence Drug R&D Market Research Report 2023
List of TablesTable 1. Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of AI Platfrom
Table 3. Key Players of Analytics Service
Table 4. Global Artificial Intelligence Drug R&D Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Artificial Intelligence Drug R&D Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Artificial Intelligence Drug R&D Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Artificial Intelligence Drug R&D Market Share by Region (2018-2023)
Table 8. Global Artificial Intelligence Drug R&D Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Artificial Intelligence Drug R&D Market Share by Region (2024-2029)
Table 10. Artificial Intelligence Drug R&D Market Trends
Table 11. Artificial Intelligence Drug R&D Market Drivers
Table 12. Artificial Intelligence Drug R&D Market Challenges
Table 13. Artificial Intelligence Drug R&D Market Restraints
Table 14. Global Artificial Intelligence Drug R&D Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Artificial Intelligence Drug R&D Market Share by Players (2018-2023)
Table 16. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug R&D as of 2022)
Table 17. Ranking of Global Top Artificial Intelligence Drug R&D Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Artificial Intelligence Drug R&D Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Artificial Intelligence Drug R&D Product Solution and Service
Table 21. Date of Enter into Artificial Intelligence Drug R&D Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2018-2023)
Table 25. Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2024-2029)
Table 27. Global Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2018-2023)
Table 29. Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2024-2029)
Table 31. North America Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Artificial Intelligence Drug R&D Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Artificial Intelligence Drug R&D Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Artificial Intelligence Drug R&D Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Artificial Intelligence Drug R&D Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2024-2029) & (US$ Million)
Table 46. IBM Watson Company Detail
Table 47. IBM Watson Business Overview
Table 48. IBM Watson Artificial Intelligence Drug R&D Product
Table 49. IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 50. IBM Watson Recent Development
Table 51. BioXel Company Detail
Table 52. BioXel Business Overview
Table 53. BioXel Artificial Intelligence Drug R&D Product
Table 54. BioXel Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 55. BioXel Recent Development
Table 56. Insilico Medicine Company Detail
Table 57. Insilico Medicine Business Overview
Table 58. Insilico Medicine Artificial Intelligence Drug R&D Product
Table 59. Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 60. Insilico Medicine Recent Development
Table 61. Gatehouse Bio Company Detail
Table 62. Gatehouse Bio Business Overview
Table 63. Gatehouse Bio Artificial Intelligence Drug R&D Product
Table 64. Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 65. Gatehouse Bio Recent Development
Table 66. Google DeepMind Company Detail
Table 67. Google DeepMind Business Overview
Table 68. Google DeepMind Artificial Intelligence Drug R&D Product
Table 69. Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 70. Google DeepMind Recent Development
Table 71. Genpact Cora Company Detail
Table 72. Genpact Cora Business Overview
Table 73. Genpact Cora Artificial Intelligence Drug R&D Product
Table 74. Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 75. Genpact Cora Recent Development
Table 76. Cyclica Inc Company Detail
Table 77. Cyclica Inc Business Overview
Table 78. Cyclica Inc Artificial Intelligence Drug R&D Product
Table 79. Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 80. Cyclica Inc Recent Development
Table 81. QuantumBlack Company Detail
Table 82. QuantumBlack Business Overview
Table 83. QuantumBlack Artificial Intelligence Drug R&D Product
Table 84. QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 85. QuantumBlack Recent Development
Table 86. Nq Medical Company Detail
Table 87. Nq Medical Business Overview
Table 88. Nq Medical Artificial Intelligence Drug R&D Product
Table 89. Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 90. Nq Medical Recent Development
Table 91. Phenomic AI Company Detail
Table 92. Phenomic AI Business Overview
Table 93. Phenomic AI Artificial Intelligence Drug R&D Product
Table 94. Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 95. Phenomic AI Recent Development
Table 96. Palantir Technologies Company Detail
Table 97. Palantir Technologies Business Overview
Table 98. Palantir Technologies Artificial Intelligence Drug R&D Product
Table 99. Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million)
Table 100. Palantir Technologies Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Intelligence Drug R&D Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Artificial Intelligence Drug R&D Market Share by Type: 2022 VS 2029
Figure 3. AI Platfrom Features
Figure 4. Analytics Service Features
Figure 5. Global Artificial Intelligence Drug R&D Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Artificial Intelligence Drug R&D Market Share by Application: 2022 VS 2029
Figure 7. Drug Discovery Case Studies
Figure 8. Precision Medicine Case Studies
Figure 9. Artificial Intelligence Drug R&D Report Years Considered
Figure 10. Global Artificial Intelligence Drug R&D Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Artificial Intelligence Drug R&D Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Artificial Intelligence Drug R&D Market Share by Region: 2022 VS 2029
Figure 13. Global Artificial Intelligence Drug R&D Market Share by Players in 2022
Figure 14. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug R&D as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Artificial Intelligence Drug R&D Revenue in 2022
Figure 16. North America Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Artificial Intelligence Drug R&D Market Share by Country (2018-2029)
Figure 18. United States Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Artificial Intelligence Drug R&D Market Share by Country (2018-2029)
Figure 22. Germany Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Artificial Intelligence Drug R&D Market Share by Region (2018-2029)
Figure 30. China Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Artificial Intelligence Drug R&D Market Share by Country (2018-2029)
Figure 38. Mexico Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Artificial Intelligence Drug R&D Market Share by Country (2018-2029)
Figure 42. Turkey Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. IBM Watson Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 45. BioXel Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 46. Insilico Medicine Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 47. Gatehouse Bio Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 48. Google DeepMind Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 49. Genpact Cora Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 50. Cyclica Inc Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 51. QuantumBlack Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 52. Nq Medical Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 53. Phenomic AI Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 54. Palantir Technologies Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Keyplayers in Global Artificial Intelligence Drug R&D Market Research Report 2023
IBM WatsonBioXel
Insilico Medicine
Gatehouse Bio
Google DeepMind
Genpact Cora
Cyclica Inc
QuantumBlack
Nq Medical
Phenomic AI
Palantir Technologies